2025 Global Insurance Market Index: Commercial Insurance Rates by Region
Global commercial insurance rates declined by 3% in Q1 2025, the third consecutive decrease in the composite rate following seven years of increases
Global Insurance Industry
“Global Insurance Industry” offers a reviews and analysis of the international insurance sector. It covers trends, challenges, and innovations shaping the industry worldwide. This category provides insights into regulatory changes, market dynamics, and technological advancements affecting global insurers. It also highlights significant developments, from mergers and acquisitions to shifts in consumer behavior.
The focus is on delivering concise, relevant information to industry professionals and stakeholders, aiding in strategic decision-making and keeping them informed about key global insurance trends.
Global Insurance Market Report: Risk Assessment for Life & Non-Life Insurers
Global Insurance Market Report shares the outcome of the Global Monitoring Exercise, the International Association of Insurance Supervisors’ (IAIS’) risk assessment framework
Aviation, Marine & Cargo Global Insurance Market Forecasts & Dynamics
The aviation, marine and cargo transit (MAT) Global Insurance Industry is estimated to grow at a compound annual growth rate of 6.4% from 2023-2026
Global Insurance Premium Volumes to Reach New High
For insurers, the main inflation impact will show in rising claims costs, more in non-life than life insurance in which policy benefits are defined at inception
Wealthy clients think about market swings, insurance gap, global instability, cyber intrusions, extreme weather, and the financial fallout of lawsuits, often all at once
European life insurers replace static SAA spreadsheets with advanced ALM tech to manage risk, capital, and yield under Solvency II and Solvency UK
Japan’s non-life insurance market — a global top-10 player and one of the largest in the region — as it continues to evolve through disciplined underwriting
AM Best shifts U.S. health insurance outlook to Negative, citing higher utilization, medical inflation, GLP-1 drug costs, and shifting Medicaid risk pools